Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 279-281, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braun, S. L.
Right arrow Articles by Mazzitelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, S. L.
Right arrow Articles by Mazzitelli, D.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2000;46:279-281.)
© 2000 American Association for Clinical Chemistry, Inc.


Technical Briefs

Plasma Troponin T and Troponin I after Minimally Invasive Coronary Bypass Surgery

Siegmund Lorenz Braun1,a, Andreas Barankay2 and Domenico Mazzitelli3

1 Institut für Laboratoriumsmedizin,
2 Institut für Anästhesiologie, and
3 Klinik für Herz- und Gefässchirurgie, Deutsches Herzzentrum München, Lazarettstrasse 36, D-80636 Munich, Germany;
a author for correspondence: fax 0049-89-1218-1013, e-mail braun@dhm.mhn.de

In the last decade, plasma cardiac troponin T (cTnT) and cardiac troponin I (cTnI) have been identified as specific and sensitive markers of myocardial cell injury (1)(2). During most types of cardiac surgery, some degree of myocardial injury regularly occurs that is dependent on multiple factors, such as the type and extent of the surgical procedure, the method of myocardial protection, the preoperative cardiac status of the patient, and the anesthetic procedures (3)(4). In recent years, minimally invasive direct coronary artery bypass grafting (MIDCAB) and off-pump coronary artery bypass grafting (OPCAB) have been introduced as alternative methods to coronary artery bypass grafting (CABG) (5). The potential advantages of MIDCAB and OPCAB arise from the avoidance of cardiopulmonary bypass (CPB) and cardioplegia. CPB always induces a systemic inflammatory response syndrome, and a substantial number of patients develop multiple organ dysfunction. However, there are also disadvantages of MIDCAB and OPCAB, including difficulty of performing the coronary anastomosis on the beating heart, ischemic damage during occlusion of the targeted vessel, and cardiac dislocation or compression to obtain optimal exposure of the vessels on the posterior wall. Currently, only limited data (6)(7)(8)(9) concerning . . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
P. V Rao, P. K Hosabettu, S. Dhaded, A. Mathew, J. Punnen, and M. Kanchi
Distal Carotid Perfusion in Combined Carotid Endarterectomy and OP-CABG
Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 164 - 166.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
N. Nesher, E. Zisman, T. Wolf, R. Sharony, G. Bolotin, M. David, G. Uretzky, and R. Pizov
Strict Thermoregulation Attenuates Myocardial Injury During Coronary Artery Bypass Graft Surgery as Reflected by Reduced Levels of Cardiac-Specific Troponin I
Anesth. Analg., February 1, 2003; 96(2): 328 - 335.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.